Diligence memo · auto-generated · as of July 3, 2026

Radius Health, Inc.

Radius Health, Inc. has raised $191M over 2 rounds; too few niche peers to rank its valuation yet.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Radius Health, Inc. operates in Pharmaceuticals, based in CAMBRIDGE.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Radius Health, Inc. has raised $191M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).

Largest single filing: $127M on 2011-05-17.

Most recent recorded round closed around 2011-05-17.

Valuation (modeled)modeled

Provath models Radius Health, Inc. at approximately $4.5B (range $604M–$9.8B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Too few comparable companies in this niche to rank the valuation fairly yet.

Financing rhythm & timingmixed

Last raise 15.1 yr ago; this sector typically re-raises about every 13 months.

Silent for over 3× the sector's normal cadence.

The last round was 2.0× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 96% of Pharmaceuticals peers (1613 compared).

Modeled value ranks above 98% of those peers.

Closest niche peers: Isis Pharmaceuticals Inc.

Peoplefiled

10 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.